X4 Pharmaceuticals Stock Price History
| XFOR Stock | USD 0.30 0.01 3.23% |
Below is the normalized historical share price chart for X4 Pharmaceuticals extending back to November 16, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of X4 Pharmaceuticals stands at 0.30, as last reported on the 20th of March, with the highest price reaching 0.32 and the lowest price hitting 0.30 during the day.
If you're considering investing in XFOR Stock, it is important to understand the factors that can impact its price. X4 Pharmaceuticals retains Efficiency (Sharpe Ratio) of -0.0631, which attests that the company had a -0.0631 % return per unit of price deviation over the last 3 months. X4 Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out X4 Pharmaceuticals' market risk adjusted performance of (2.28), and Information Ratio of (0.07) to validate the risk estimate we provide.
At this time, X4 Pharmaceuticals' Common Stock Total Equity is relatively stable compared to the past year. As of 03/20/2025, Common Stock Shares Outstanding is likely to grow to about 214.7 M, while Liabilities And Stockholders Equity is likely to drop slightly above 102.4 M. . At this time, X4 Pharmaceuticals' Price To Sales Ratio is relatively stable compared to the past year. As of 03/20/2025, Price Book Value Ratio is likely to grow to 2.76, while Price To Operating Cash Flows Ratio is likely to drop (1.46). XFOR Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of November 2017 | 200 Day MA 0.6175 | 50 Day MA 0.4772 | Beta 0.389 |
XFOR |
Sharpe Ratio = -0.0631
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | XFOR |
Estimated Market Risk
| 10.82 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.68 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average X4 Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of X4 Pharmaceuticals by adding X4 Pharmaceuticals to a well-diversified portfolio.
Price Book 0.857 | Enterprise Value Ebitda 1.1003 | Price Sales 45.4992 | Shares Float 128.2 M | Wall Street Target Price 3.125 |
X4 Pharmaceuticals Stock Price History Chart
There are several ways to analyze XFOR Stock price data. The simplest method is using a basic XFOR candlestick price chart, which shows X4 Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 26, 2024 | 0.81 |
| Lowest Price | March 10, 2025 | 0.3 |
X4 Pharmaceuticals March 20, 2025 Stock Price Synopsis
Various analyses of X4 Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell XFOR Stock. It can be used to describe the percentage change in the price of X4 Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of XFOR Stock.| X4 Pharmaceuticals Price Action Indicator | (0.02) | |
| X4 Pharmaceuticals Accumulation Distribution | 62,268 | |
| X4 Pharmaceuticals Price Daily Balance Of Power | (0.50) | |
| X4 Pharmaceuticals Price Rate Of Daily Change | 0.97 |
X4 Pharmaceuticals March 20, 2025 Stock Price Analysis
XFOR Stock Price History Data
The price series of X4 Pharmaceuticals for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 0.51 with a coefficient of variation of 27.09. The daily prices for the period are distributed with arithmetic mean of 0.53. The median price for the last 90 days is 0.51. The company experienced 1:6 stock split on 14th of March 2019. X4 Pharmaceuticals paid out dividends to its shareholders on 2019-03-14.| Open | High | Low | Close | Volume | ||
| 03/20/2025 | 0.30 | 0.32 | 0.30 | 0.30 | 996,291 | |
| 03/19/2025 | 0.30 | 0.30 | 0.29 | 0.30 | 1,076,838 | |
| 03/18/2025 | 0.32 | 0.32 | 0.29 | 0.30 | 2,690,400 | |
| 03/17/2025 | 0.33 | 0.34 | 0.31 | 0.31 | 1,457,600 | |
| 03/14/2025 | 0.33 | 0.35 | 0.32 | 0.34 | 1,409,332 | |
| 03/13/2025 | 0.34 | 0.35 | 0.32 | 0.32 | 800,900 | |
| 03/12/2025 | 0.32 | 0.36 | 0.31 | 0.34 | 1,513,300 | |
| 03/11/2025 | 0.31 | 0.33 | 0.30 | 0.32 | 1,893,300 | |
| 03/10/2025 | 0.34 | 0.36 | 0.30 | 0.30 | 2,110,700 | |
| 03/07/2025 | 0.38 | 0.38 | 0.35 | 0.35 | 1,931,300 | |
| 03/06/2025 | 0.38 | 0.38 | 0.36 | 0.38 | 927,400 | |
| 03/05/2025 | 0.37 | 0.38 | 0.35 | 0.37 | 1,602,200 | |
| 03/04/2025 | 0.36 | 0.38 | 0.34 | 0.37 | 1,600,500 | |
| 03/03/2025 | 0.41 | 0.42 | 0.36 | 0.36 | 1,283,400 | |
| 02/28/2025 | 0.37 | 0.40 | 0.36 | 0.40 | 1,268,100 | |
| 02/27/2025 | 0.40 | 0.42 | 0.36 | 0.37 | 1,748,558 | |
| 02/26/2025 | 0.43 | 0.45 | 0.40 | 0.41 | 1,625,900 | |
| 02/25/2025 | 0.45 | 0.46 | 0.42 | 0.44 | 1,018,600 | |
| 02/24/2025 | 0.49 | 0.49 | 0.44 | 0.45 | 951,700 | |
| 02/21/2025 | 0.49 | 0.49 | 0.47 | 0.47 | 962,100 | |
| 02/20/2025 | 0.50 | 0.51 | 0.47 | 0.47 | 1,210,100 | |
| 02/19/2025 | 0.51 | 0.52 | 0.50 | 0.50 | 1,828,600 | |
| 02/18/2025 | 0.52 | 0.54 | 0.49 | 0.50 | 1,239,300 | |
| 02/14/2025 | 0.50 | 0.51 | 0.49 | 0.51 | 890,600 | |
| 02/13/2025 | 0.49 | 0.52 | 0.48 | 0.50 | 1,244,100 | |
| 02/12/2025 | 0.46 | 0.49 | 0.46 | 0.48 | 1,440,500 | |
| 02/11/2025 | 0.51 | 0.51 | 0.47 | 0.47 | 2,921,200 | |
| 02/10/2025 | 0.53 | 0.54 | 0.50 | 0.51 | 2,366,100 | |
| 02/07/2025 | 0.56 | 0.57 | 0.52 | 0.53 | 1,465,900 | |
| 02/06/2025 | 0.50 | 0.60 | 0.50 | 0.55 | 4,824,313 | |
| 02/05/2025 | 0.60 | 0.66 | 0.58 | 0.62 | 2,951,100 | |
| 02/04/2025 | 0.58 | 0.64 | 0.56 | 0.60 | 2,520,300 | |
| 02/03/2025 | 0.65 | 0.67 | 0.60 | 0.60 | 3,765,500 | |
| 01/31/2025 | 0.63 | 0.81 | 0.62 | 0.70 | 16,832,000 | |
| 01/30/2025 | 0.81 | 0.81 | 0.63 | 0.66 | 39,967,200 | |
| 01/29/2025 | 0.49 | 0.80 | 0.46 | 0.74 | 42,500,200 | |
| 01/28/2025 | 0.49 | 0.52 | 0.47 | 0.48 | 1,139,700 | |
| 01/27/2025 | 0.43 | 0.50 | 0.43 | 0.49 | 2,339,000 | |
| 01/24/2025 | 0.52 | 0.53 | 0.45 | 0.48 | 4,262,000 | |
| 01/23/2025 | 0.49 | 0.54 | 0.49 | 0.52 | 1,111,000 | |
| 01/22/2025 | 0.49 | 0.51 | 0.48 | 0.49 | 1,177,500 | |
| 01/21/2025 | 0.51 | 0.53 | 0.47 | 0.49 | 1,706,200 | |
| 01/17/2025 | 0.48 | 0.54 | 0.46 | 0.51 | 1,678,300 | |
| 01/16/2025 | 0.46 | 0.48 | 0.43 | 0.46 | 2,464,200 | |
| 01/15/2025 | 0.46 | 0.49 | 0.46 | 0.46 | 2,102,200 | |
| 01/14/2025 | 0.57 | 0.57 | 0.46 | 0.46 | 3,842,400 | |
| 01/13/2025 | 0.60 | 0.60 | 0.50 | 0.56 | 11,347,300 | |
| 01/10/2025 | 0.64 | 0.66 | 0.57 | 0.57 | 1,618,700 | |
| 01/08/2025 | 0.70 | 0.71 | 0.61 | 0.64 | 1,943,400 | |
| 01/07/2025 | 0.73 | 0.77 | 0.70 | 0.70 | 1,140,300 | |
| 01/06/2025 | 0.74 | 0.77 | 0.68 | 0.74 | 2,907,700 | |
| 01/03/2025 | 0.78 | 0.79 | 0.72 | 0.74 | 2,137,600 | |
| 01/02/2025 | 0.74 | 0.82 | 0.73 | 0.75 | 1,362,700 | |
| 12/31/2024 | 0.85 | 0.89 | 0.73 | 0.73 | 1,669,400 | |
| 12/30/2024 | 0.81 | 0.86 | 0.73 | 0.81 | 2,215,900 | |
| 12/27/2024 | 0.79 | 0.86 | 0.77 | 0.80 | 2,931,600 | |
| 12/26/2024 | 0.60 | 0.84 | 0.60 | 0.81 | 7,732,400 | |
| 12/24/2024 | 0.58 | 0.62 | 0.53 | 0.58 | 1,809,000 | |
| 12/23/2024 | 0.62 | 0.65 | 0.57 | 0.58 | 1,430,300 | |
| 12/20/2024 | 0.59 | 0.68 | 0.57 | 0.61 | 3,325,300 | |
| 12/19/2024 | 0.65 | 0.68 | 0.60 | 0.61 | 1,569,900 |
About X4 Pharmaceuticals Stock history
X4 Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XFOR is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in X4 Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing X4 Pharmaceuticals stock prices may prove useful in developing a viable investing in X4 Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 204.5 M | 214.7 M | |
| Net Loss | -86.8 M | -82.4 M |
X4 Pharmaceuticals Quarterly Net Working Capital |
|
X4 Pharmaceuticals Stock Technical Analysis
X4 Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
X4 Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for X4 Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of XFOR Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XFOR to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.86) | |||
| Total Risk Alpha | 0.0444 | |||
| Treynor Ratio | (2.29) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for XFOR Stock Analysis
When running X4 Pharmaceuticals' price analysis, check to measure X4 Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy X4 Pharmaceuticals is operating at the current time. Most of X4 Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of X4 Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move X4 Pharmaceuticals' price. Additionally, you may evaluate how the addition of X4 Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.